COVID-19: After the Crisis
Latest Updates:Due to the rapidly changing information available on COVID-19, this page is updated frequently. The latest updates include:
- Three Foundational Steps to Restart Elective Cases links to content within the page
- Contact Tracing links to content within the page
Resuming Deferred Procedures
Many U.S. hospitals and health systems heeded guidance from the Centers for Medicare & Medicaid Services (CMS) (March 18) and others to pause on any non-emergent/non-urgent surgeries and procedures as a strategy to preserve PPE and other finite resources, including healthcare workforce, early in the pandemic.
At this juncture, CMS has provided guidanceopens in a new tab for facilities to begin to resume performing deferred procedures, such as elective surgeries. Elective surgeries are considered those procedures that are preplanned by both the patient and the physician that are advantageous to the patient but are not urgent or emergent. The American College of Surgeons, American Society of Anesthesiologists, Association of periOperative Registered Nurses and American Hospital Association have also issued a joint statementopens in a new tab and have shared their roadmap to operationalizing resumption of surgeries. The following information, resources and tools are provided to support organizations to thoughtfully and practically re-engage and scale up to resume normal, safe, full-service surgery and procedural services.
Three critical operational considerations are:
- Adequate, appropriate PPE opens in a new tab for healthcare workers
- Appropriate staffing
- Testing capabilities and capacity
Premier Healthcare Alliance:
- Three Foundational Steps to Restart Elective Cases (May 11) opens in a new tab
- Practices to Carry Forward from the Pandemic (April 28) opens in a new tab – Strategies, resources and tools to thrive.
- Diagnostic – are you currently infected with SARS-CoV-2, the virus that causes COVID-19
- Serologic (“antibody test”) – you have had a recent SARS-CoV-2 infection
Although the CDC has guidance for who should be tested, decisions about testing are made by state and local health departments or healthcare providers. The CDC’s “COVID-19 Testing” information and resources are available here opens in a new tab.
FDA – Emergency Use Authorization (EUA) – COVID-19 resources opens in a new tab. Lists current and terminated EUAs for diagnostic and therapeutic medical devices used to diagnose and respond to the COVID-19 public health emergency, including both PPE and in vitro diagnostics.FDA – Serology/Antibody Tests FAQs opens in a new tab
- Association of State and Territorial Health Officials (ASTHO) – A Coordinated, National Approach to Scaling Public Health Capacity for Contact Tracing and Disease Investigation opens in a new tab
- CDC – Principles of Contact Tracing opens in a new tab
- CDC – COVID-19 Contact Tracing Training Guidance and Resources opens in a new tab
- CDC – Fact Sheet: National Service Resources to Support COVID-19 Contact tracing opens in a new tab
Second Wave: Surge Preparedness
In the past three most memorable pandemics, 1918’s Spanish flu, 1968’s Hong Kong flu and 2009’s H1N1 flu, the second wave was consistently deadlier than the first. We are now dealing with the first wave of COVID-19, and there is no reason to expect this pandemic will behave differently. Organizations must prepare for surge and wave 2 now, even as you recover from wave 1. CDC’s COVID-19Surge opens in a new tab tool is invaluable in planning.
For more information and resources to support surge preparedness, click herePSI page COVID Surge Preparedness.